HSL Mobile App
Concord Drugs Ltd
27 May 2026 12:00 AM
Concord Drugs consolidated net profit rises 1225.00% in the March 2026 quarter,
Net profit of Concord Drugs rose 1225.00% to Rs 0.53 crore in the quarter ended March 2026 as against Rs 0.04 crore during the previous quarter ended March 2025. Sales rose 264.68% to Rs 37.89 crore in the quarter ended March 2026 as against Rs 10.39 crore during the previous quarter ended March 2025.For the full year,net profit rose 211.76% to Rs 1.06 crore in the year ended March 2026 as against Rs 0.34 crore during the previous year ended March 2025. Sales rose 74.05% to Rs 78.74 crore in the year ended March 2026 as against Rs 45.24 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales37.8910.39 265 78.7445.24 74 OPM %3.9610.11 -5.789.17 - PBDT1.100.44 150 2.842.12 34 PBT0.750.06 1150 1.470.69 113 NP0.530.04 1225 1.060.34 212 Powered by Capital Market - Live News
Concord Drugs Ltd
19 May 2026 12:00 AM
Concord Drugs to hold board meeting,
Concord Drugs will hold a meeting of the Board of Directors of the Company on 27 May 2026.
Concord Drugs Ltd
17 Feb 2026 12:00 AM
Concord Drugs consolidated net profit declines 4.35% in the December 2025 quarter,
Net profit of Concord Drugs declined 4.35% to Rs 0.22 crore in the quarter ended December 2025 as against Rs 0.23 crore during the previous quarter ended December 2024. Sales rose 57.13% to Rs 16.97 crore in the quarter ended December 2025 as against Rs 10.80 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales16.9710.80 57 OPM %5.5412.87 - PBDT0.600.90 -33 PBT0.300.53 -43 NP0.220.23 -4 Powered by Capital Market - Live News
Concord Drugs Ltd
03 Feb 2026 12:00 AM
Concord Drugs to declare Quarterly Results,
Concord Drugs will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News
Concord Drugs Ltd
14 Nov 2025 12:00 AM
Concord Drugs consolidated net profit rises 375.00% in the September 2025 quarter,
Net profit of Concord Drugs rose 375.00% to Rs 0.19 crore in the quarter ended September 2025 as against Rs 0.04 crore during the previous quarter ended September 2024. Sales declined 16.83% to Rs 10.28 crore in the quarter ended September 2025 as against Rs 12.36 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales10.2812.36 -17 OPM %10.707.12 - PBDT0.610.41 49 PBT0.270.07 286 NP0.190.04 375 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
